Analysis of Planning and Drug Procurement at Kragan II Public Health Center during Covid-19 Pandemic

Fitrotul Maulidiyyah; Bambang Budi Rahardjo

doi:10.14710/jphtcr.v5i3.14202

DOI: https://doi.org/10.14710/jphtcr.v5i3.14202

Analysis of Planning and Drug Procurement at Kragan II Public Health Center during Covid-19 Pandemic

Fitrotul Maulidiyyah¹ , Bambang Budi Rahardjo²

¹Department of Public Health, Universitas Negeri Semarang, Semarang, Indonesia

²Department of Public Health, Universitas Negeri Semarang, Semarang, Indonesia

Received: 11 May 2022; Published: 28 Dec 2022.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

BibTex Citation Data :

@article{JPHTCR14202,
    author = {Fitrotul Maulidiyyah and Bambang Budi Rahardjo},
    title = {Analysis of Planning and Drug Procurement at Kragan II Public Health Center during Covid-19 Pandemic},
    journal = {Journal of Public Health for Tropical and Coastal Region},
  volume = {5},
    number = {3},
    year = {2022},
    keywords = {COVID-19 pandemic, Drug Planning, Drug Procurement},
    abstract = {  Introduction:  Based on the results of a preliminary study at the Kragan II Health Center, Kragan District, Rembang Regency, it was found that problems in drug procurement activities were located on the Large Pharmaceutical Trader or  Pedagang Besar Farmasi  (PBF). In addition, the COVID-19 pandemic has also affected the budget cuts for the procurement of drugs at the Kragan II Health Center.   Methods:  This research was descriptive qualitative research. Data collection techniques use in-depth interviews and observation techniques. The sampling technique used was purposive sampling and data were analyzed using the Miles and Huberman model.   Results : The results showed that the process of planning and supplying drugs at the Kragan II Health Center had not gone well even though the indicators in Regulation of the Minister of Health Number 74 of 2016 of the Republic of Indonesia had been realized. The process of planning and procuring drugs at the Kragan II Health Center  (Puskesmas)  experienced problems in the field of funding for the procurement of drugs due to the Covid-19 pandemic. Another problem is the PBF whose response is slow and the drugs distributed are not following what was ordered by the pharmacist.   Conclusion : Regarding debts with PBF, pharmacists are advised to discuss with the Head of the Kragan II Health Center regarding budget priorities during the COVID-19 pandemic to immediately pay off debts with PBF so that pharmacists can procure with PBF again. Therefore, drug services to patients can run well. },
   issn = {2597-4378},   pages = {113--127}  doi = {10.14710/jphtcr.v5i3.14202},
    url = {https://ejournal2.undip.ac.id/index.php/jphtr/article/view/14202}
}

Citation Format:

Abstract

Introduction: Based on the results of a preliminary study at the Kragan II Health Center, Kragan District, Rembang Regency, it was found that problems in drug procurement activities were located on the Large Pharmaceutical Trader or Pedagang Besar Farmasi (PBF). In addition, the COVID-19 pandemic has also affected the budget cuts for the procurement of drugs at the Kragan II Health Center.

Methods: This research was descriptive qualitative research. Data collection techniques use in-depth interviews and observation techniques. The sampling technique used was purposive sampling and data were analyzed using the Miles and Huberman model.

Results: The results showed that the process of planning and supplying drugs at the Kragan II Health Center had not gone well even though the indicators in Regulation of the Minister of Health Number 74 of 2016 of the Republic of Indonesia had been realized. The process of planning and procuring drugs at the Kragan II Health Center (Puskesmas) experienced problems in the field of funding for the procurement of drugs due to the Covid-19 pandemic. Another problem is the PBF whose response is slow and the drugs distributed are not following what was ordered by the pharmacist.

Conclusion: Regarding debts with PBF, pharmacists are advised to discuss with the Head of the Kragan II Health Center regarding budget priorities during the COVID-19 pandemic to immediately pay off debts with PBF so that pharmacists can procure with PBF again. Therefore, drug services to patients can run well.

Note: This article has supplementary file(s).

Fulltext View|Download | common.other

Untitled

Subject
Type	Other
	Download (418KB) Indexing metadata

Keywords: COVID-19 pandemic, Drug Planning, Drug Procurement

Article Metrics:

Article Info

Section: Articles

Language : EN

In Vol 5, No 3 (2022): Journal of Public Health for Tropical and Coastal Region

Recent articles

Analysis of Planning and Drug Procurement at Kragan II Public Health Center during Covid-19 Pandemic The Relationship of Energy and Macro nutrient Intake on Fatigue Levels of Female Workers at The Bandarharjo Fish Smoking Center, Semarang City Risk Factors Associated with Disability among Elderly with Stroke in Indonesia: A Secondary Data Analysis of 2018 National Basic Health Research More recent articles

Binagwaho A, Ghebreyesus TA. Primary healthcare is cornerstone of universal health coverage. In: The BMJ. 2019. p. 2391
Rahmah F. Perencanaan dan Pengadaan Obat di Puskesmas “X” Berdasarkan Permenkes Nomor 74 Tahun 2016. J Adm Kesehat Indones. 2018;6(1):15
Nibong CR, Kolibu FK, Mandagi CKF. Analisis Perencanaan dan Pengadaan Obat di Puskesmas Sario Kota Manado. J Kesehat Masy SAM RATULANGI [Internet]. 2017;6(3):1–12. Available from: https://ejournal.unsrat.ac.id/index.php/kesmas/article/view/23033
Kementerian Kesehatan RI. Peraturan Menteri Kesehatan Republik Indonesia Nomor 74 Tahun 2016 Tentang Standar Pelayanan Kefarmasian di Puskesmas. Jakarta: Kemenkes RI; 2016. 1–48 p
Alatas H, Karyomanggolo W, Musa DA, Boediarso A, Oesman IN, Idris NS. Desain Penelitian. In: Sastroasmoro S, Ismael S, editors. Dasar-dasar Metodologi Penelitian Klinis. 5th ed. Jakarta: Sagung Seto; 2014. p. 104–30
Sugiyono. Metode Penelitian Kuantitatif, Kualitatif, dan R&D. 22nd ed. Bandung: ALFABETA CV; 2015. 205–277 p
Roza S, Pratiwi E, Dewi RS, Sinata N. Gambaran Perencanaan dan Pengadaan Obat di Puskesmas Rawat Jalan Kabupaten Rokan Hulu Tahun 2018. J Penelit Farm Indones. 2019;8(2):85–90
Puspadina V, Oetari O, Widodo GP. Evaluasi Performa Supply Chain Management Pedagang Besar Farmasi Terhadap Proses Pengadaan Di Apotek Kimia Farma Unit Bisnis Sidoarjo. JPSCR J Pharm Sci Clin Res. 2021;6(1):49

Last update:

No citation recorded.

Last update:

No citation recorded.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

In order to be accepted and published by Journal of Public Health for Tropical and Coastal Region, the author (s) who submit a manuscript should complete the review process. Journal of Public Health for Tropical and Coastal Region articles are distributed under a Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0). Articles can be read, shared, and adapted even for commercial purposes under the following conditions:

Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

The copyright of received articles is assigned to the author (s). The author (s) have the right to the articles that have been published. The Editorial Team of Journal of Public Health for Tropical and Coastal Region and the Author(s) strive to ensure that no errors occur in the articles that have been published, both data errors and statements in the articles. Authors who publish in this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
The journal allows the authors to hold the copyright and retain publishing rights without restrictions.
Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during submission, as it can lead to productive exchanges and earlier and greater citation of published work.